Individualised neoantigen cancer vaccine therapy

Lancet. 2024 Feb 17;403(10427):590-591. doi: 10.1016/S0140-6736(23)02463-7. Epub 2024 Jan 18.

Authors

Mizue Terai¹, Takami Sato²

Affiliations

¹ Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA.
² Department of Medical Oncology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA. Electronic address: takami.sato@jefferson.edu.

PMID: 38246193
DOI: 10.1016/S0140-6736(23)02463-7

No abstract available

MeSH terms

Cancer Vaccines* / therapeutic use
Humans
Immunotherapy
Mutation
Neoplasms* / therapy

Substances

Cancer Vaccines